Can genetically modified mosquitoes stop the spread of dangerous viruses like Zika and dengue?
In short: Scientists are releasing laboratory-engineered mosquitoes into the wild to combat disease-carrying populations. By introducing specific genes that prevent female offspring from surviving, researchers aim to crash the numbers of Aedes aegypti mosquitoes. But as these programs expand, experts are weighing the long-term ecological impact against the urgent need for prevention.
The Aedes aegypti mosquito is a primary vector for severe illnesses, including dengue, Zika, yellow fever, and chikungunya. Traditional control methods, such as insecticides, often carry the unintended consequence of harming beneficial insects like butterflies and honey bees. In response, researchers have developed genetically modified (GM) mosquitoes as a targeted alternative. These insects are engineered with a self-limiting gene that prevents female offspring from reaching adulthood, alongside a fluorescent marker gene that allows scientists to track them under red light.
When released into the wild, these male GM mosquitoes mate with local females, passing the self-limiting trait to their offspring. Because only female mosquitoes bite to obtain the blood meals necessary for egg production, reducing the population of this specific species is intended to lower the risk of disease outbreaks. The Environmental Protection Agency (EPA) has authorized the release of specific GM strains, such as OX5034, in parts of Florida and Texas, following assessments that determined no significant risk to people, animals, or the environment. Since 2019, over 1 billion of these mosquitoes have been released globally in countries including Brazil, Panama, and India.
Despite the promise of this technology, it remains a subject of ongoing study. A systematic review of research published up to 2016 highlighted that while modification strategies are promising, field-based evidence regarding long-term epidemiological impact is still scarce. Some studies have reported variability in results, including instances where vector populations increased post-release or where horizontal gene transfer occurred. Furthermore, because GM mosquitoes only target one species, they must be used alongside integrated management approaches to address the diverse mosquito populations found in most communities. As of now, these technologies have not yet been approved by the World Health Organization’s Vector Control Advisory Group, underscoring the need for continued rigorous evaluation of both efficacy and ecological safety.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Could GM Mosquitoes Reduce Disease?
- Also: Genetically Modified Mosquitoes
- Also: What happens when we modify mosquitoes for disease prevention? A systematic review
To cite this card, link to https://intellectplus.co.uk/app/ideas-could-gm-mosquitoes-reduce-disease.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
